199 related articles for article (PubMed ID: 22711539)
1. Role of melanoma inhibitor of apoptosis (ML-IAP) protein, a member of the baculoviral IAP repeat (BIR) domain family, in the regulation of C-RAF kinase and cell migration.
Oberoi-Khanuja TK; Karreman C; Larisch S; Rapp UR; Rajalingam K
J Biol Chem; 2012 Aug; 287(34):28445-55. PubMed ID: 22711539
[TBL] [Abstract][Full Text] [Related]
2. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.
Vucic D; Stennicke HR; Pisabarro MT; Salvesen GS; Dixit VM
Curr Biol; 2000 Nov; 10(21):1359-66. PubMed ID: 11084335
[TBL] [Abstract][Full Text] [Related]
3. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
4. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP).
Vucic D; Deshayes K; Ackerly H; Pisabarro MT; Kadkhodayan S; Fairbrother WJ; Dixit VM
J Biol Chem; 2002 Apr; 277(14):12275-9. PubMed ID: 11801603
[TBL] [Abstract][Full Text] [Related]
5. X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility.
Dogan T; Harms GS; Hekman M; Karreman C; Oberoi TK; Alnemri ES; Rapp UR; Rajalingam K
Nat Cell Biol; 2008 Dec; 10(12):1447-55. PubMed ID: 19011619
[TBL] [Abstract][Full Text] [Related]
6. Increased cytotoxicity of cisplatin in SK-MEL 28 melanoma cells upon down-regulation of melanoma inhibitor of apoptosis protein.
Mousavi-Shafaei P; Ziaee AA; Zangemeister-Wittke U
Iran Biomed J; 2009 Jan; 13(1):27-34. PubMed ID: 19252675
[TBL] [Abstract][Full Text] [Related]
7. MAPK and Hippo signaling pathways crosstalk via the RAF-1/MST-2 interaction in malignant melanoma.
Feng R; Gong J; Wu L; Wang L; Zhang B; Liang G; Zheng H; Xiao H
Oncol Rep; 2017 Aug; 38(2):1199-1205. PubMed ID: 28677804
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem-Like Cell Fate in an Oxygen-Dependent Manner.
Soubéran A; Cappaï J; Chocry M; Nuccio C; Raujol J; Colin C; Lafitte D; Kovacic H; Quillien V; Baeza-Kallee N; Rougon G; Figarella-Branger D; Tchoghandjian A
Stem Cells; 2019 Jun; 37(6):731-742. PubMed ID: 30920104
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspase.
Yan H; Brouha B; Liu T; Raj D; Biddle D; Lee R; Grossman D
J Dermatol Sci; 2006 Sep; 43(3):189-200. PubMed ID: 16806840
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
[TBL] [Abstract][Full Text] [Related]
12. IAPs: more than just inhibitors of apoptosis proteins.
Dubrez-Daloz L; Dupoux A; Cartier J
Cell Cycle; 2008 Apr; 7(8):1036-46. PubMed ID: 18414036
[TBL] [Abstract][Full Text] [Related]
13. Characterization of ML-IAP protein stability and physiological role in vivo.
Varfolomeev E; Moradi E; Dynek JN; Zha J; Fedorova AV; Deshayes K; Fairbrother WJ; Newton K; Le Couter J; Vucic D
Biochem J; 2012 Nov; 447(3):427-36. PubMed ID: 22853455
[TBL] [Abstract][Full Text] [Related]
14.
Ng HQ; Li Q; Kang C
Biomol NMR Assign; 2022 Apr; 16(1):91-95. PubMed ID: 35061233
[TBL] [Abstract][Full Text] [Related]
15. Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance.
Silke J; Kratina T; Chu D; Ekert PG; Day CL; Pakusch M; Huang DC; Vaux DL
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16182-7. PubMed ID: 16263936
[TBL] [Abstract][Full Text] [Related]
16. Livin, a novel inhibitor of apoptosis protein family member.
Kasof GM; Gomes BC
J Biol Chem; 2001 Feb; 276(5):3238-46. PubMed ID: 11024045
[TBL] [Abstract][Full Text] [Related]
17. Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP).
Franklin MC; Kadkhodayan S; Ackerly H; Alexandru D; Distefano MD; Elliott LO; Flygare JA; Mausisa G; Okawa DC; Ong D; Vucic D; Deshayes K; Fairbrother WJ
Biochemistry; 2003 Jul; 42(27):8223-31. PubMed ID: 12846571
[TBL] [Abstract][Full Text] [Related]
18. Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas.
Gong J; Chen N; Zhou Q; Yang B; Wang Y; Wang X
J Clin Pathol; 2005 Oct; 58(10):1081-5. PubMed ID: 16189155
[TBL] [Abstract][Full Text] [Related]
19. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma.
Nachmias B; Ashhab Y; Bucholtz V; Drize O; Kadouri L; Lotem M; Peretz T; Mandelboim O; Ben-Yehuda D
Cancer Res; 2003 Oct; 63(19):6340-9. PubMed ID: 14559822
[TBL] [Abstract][Full Text] [Related]
20. Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells.
Engesæter BO; Sathermugathevan M; Hellenes T; Engebråten O; Holm R; Flørenes VA; Mælandsmo GM
Cancer Biol Ther; 2011 Jul; 12(1):47-58. PubMed ID: 21508672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
